RB
Richard C Breeden
Director

Richard C Breeden insider trades: STERIS (STE) stock buys and sales

Director, STERIS Last trade Jun 2, 2026 69 Form 4 filings
$310K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2008
5
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Richard reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 2, 2026STE↓ Sell$310K
May 16, 2023STE↓ Sell$2.5M
May 15, 2023STE↓ Sell$578K
Aug 25, 2020STE↓ Sell$6.9M
May 15, 2012ZLC↓ Sell$582K
Nov 26, 2008ZLC↑ Buy$6.3M
Oct 27, 2008HRB↑ Buy$50.0M
Apr 9, 2008HRB↑ Buy$43.5M
Mar 20, 2008HRB↑ Buy$47.8M
Jan 14, 2008ZLC↑ Buy$2.6M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other STE insiders

Open-market trades in the last 12 months

About Richard C Breeden's insider trades

Richard C Breeden is a director at STERIS (STE). Since Jan 14, 2008, Richard has reported 5 open-market purchases worth $150.2M and 5 sales worth $10.9M on SEC Form 4. In the last 12 months: 1 sale ($310K).

Their filings also include grants and awards (40 filings), option exercises (9 filings), other transactions (7 filings), shares returned to the company (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every STE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.